Vg Life Sciences

(OTC) VGLS

Current Price$0.40

Market Cap$421.90K

Since IPO (2001)-100%

5 Year-100%

1 Year-80%

1 Month+3%

Vg Life Sciences Financials at a Glance

Market Cap

$421.90K

Revenue (TTM)

$0.00

Net Income (TTM)

-$355.18K

EPS (TTM)

-$0.20

P/E Ratio

-2.00

Dividend

$0.00

Beta (Volatility)

48.62 (High)

Dividend

$0.00

Beta (Volatility)

48.62 (High)

Price

$0.40

Volume

2,578

Open

$0.75

Price

$0.40

Volume

2,578

Open

$0.75

Previous Close

$0.40

Daily Range

$0.40 - $0.75

52-Week Range

$0.02 - $2.25

Estimated Earnings Date

Nov 5, 2025

Dividend

$0.00

Beta (Volatility)

48.62 (High)

Price

$0.40

Volume

2,578

Open

$0.75

Previous Close

$0.40

Daily Range

$0.40 - $0.75

52-Week Range

$0.02 - $2.25

Estimated Earnings Date

Nov 5, 2025

VGLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vg Life Sciences

Industry

Biotechnology

Sector

Health Care

CEO

William P. Farrand

Website

vglscorp.com

Headquarters

New York, NY 10013, US

VGLS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$421.90K

Shares Outstanding

1.05M

Volume

2.58K

Avg. Volume

10.61K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$296.55K

EBITDA

-$296.55K

Operating Cash Flow

-$20.34K

Capital Expenditure

$0.00

Free Cash Flow

-$20.34K

Cash & ST Invst.

$0.00

Total Debt

$2.18M

Vg Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$421.90K

N/A

Market Cap/Employee

$421.90K

N/A

Employees

N/A

Net Income

$199.73K

+176.3%

EBITDA

-$78.60K

+70.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

-$2.11M

-3.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.11M

+3.4%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$6.19K

-52.0%

Operating Cash Flow

-$6.19K

-52.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+0.00%

AGTXAgentix Corp.

AGTXAgentix Corp.$0.02+0.00%

AGNPFAlgernon Pharmaceuticals Inc.

AGNPFAlgernon Pharmaceuticals Inc.$0.34+6.63%

APLIFAppili Therapeutics Inc.

APLIFAppili Therapeutics Inc.$0.01+0.00%

HESGHealth Sciences Group, Inc.

HESGHealth Sciences Group, Inc.$0.00+0.00%

AAGHAmerica Great Health

AAGHAmerica Great Health$0.00+0.00%

IBOGFUniversal Ibogaine Inc.

IBOGFUniversal Ibogaine Inc.$0.03-7.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About VGLS

What is the current price of Vg Life Sciences?

Vg Life Sciences is trading at $0.40 per share.

What is the 52-week range for Vg Life Sciences?

Over the past 52 weeks, Vg Life Sciences has traded between $0.02 and $2.25.

How much debt does Vg Life Sciences have?

As of the most recent reporting period, Vg Life Sciences reported total debt of $486.15K.

How much cash does Vg Life Sciences have on hand?

Vg Life Sciences reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Vg Life Sciences’s dividend yield?

Vg Life Sciences does not currently have a dividend yield.

Vg Life Sciences

Vg Life Sciences Financials at a Glance

VGLS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vg Life Sciences

VGLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vg Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VGLS

What is the current price of Vg Life Sciences?

What is the 52-week range for Vg Life Sciences?

How much debt does Vg Life Sciences have?

How much cash does Vg Life Sciences have on hand?

What is Vg Life Sciences’s dividend yield?

Premium Investing Services